ReviewESMO gastrointestinal oncology2025
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany.
S Lonardi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.